Calcobutrol

• 

Calcobutrol

CAS No.:

Molecular formula: C18H32CaN4O9

Molecular weight: 488.5461

Quality standard: CP

Characteristics: White or off-white powder

Content (HPLC): ≥99.0%

Packing: 2KG/ drum

Storage: Protected from light, sealed tightly

Beilualso provides different types of contrast media in ct scan, click here to check out.

Другие товары поставщика

	Glimepiride Tablets	Glimepiride Tablets is a sulfonylurea hypoglycemic drug that can be used in combination with insulin. In 2001, Glimepiride tablets (Dibei), as the ...
	Ferric Ammonium Citrate Effervescent Granules	Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resonance contrast agent/media approved by NMPA in the m...
	Calcobutrol	CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Quality standard: CP Characteristics: White or off-white powder ...
	CT/X-Ray Contrast Media	The main component of CT/X-ray Contrast Media is iodine. The Iodinated Contrast Media is a colorless, transparent, slightly viscous liquid. At pres...
	Iodixanol Injection	Founded in 1992, BeijingBeiluPharmaceuticalsCompanyLimitedis mainly engaged in the research & development, production and sales of pharmaceutic...

Похожие товары

	Custom Peptide Synthesis Services	Продавец: PeptiOrigin Biotechnology Co., Ltd.	Custom Peptide Synthesis Services Tailored Peptide Solutions for Research and Industry At...
	Peptide Drug Delivery	Продавец: PeptiOrigin Biotechnology Co., Ltd.	Peptide Drug Delivery Precision Delivery for Enhanced Therapeutic and Cosmetic Applications ...
	Ferric Ammonium Citrate Effervescent Granules	Продавец: Beijing Beilu Pharmaceutical Co., Ltd	Ferric Ammonium Citrate Effervescent Granules was launched in 2004. It is an oral magnetic resona...
	Calcobutrol	Продавец: Beijing Beilu Pharmaceutical Co., Ltd	Calcobutrol CAS No.: Molecular formula: C18H32CaN4O9 Molecular weight: 488.5461 Qualit...
	Anti-Diabetic Drugs	Продавец: Beijing Beilu Pharmaceutical Co., Ltd	The number of people with diabetes rose from 151 million in 2000 to 463 million in 2019; by 2045 ...